• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA 甲基化抑制人肝癌细胞尿素循环酶氨甲酰磷酸合成酶 1(CPS1)的表达。

DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma.

机构信息

Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, USA.

出版信息

Am J Pathol. 2011 Feb;178(2):652-61. doi: 10.1016/j.ajpath.2010.10.023.

DOI:10.1016/j.ajpath.2010.10.023
PMID:21281797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3069978/
Abstract

Carbamoyl phosphate synthetase 1 (CPS1) is a liver-specific, intramitochondrial, rate-limiting enzyme in the urea cycle. A previous study showed that CPS1 is the antigen for hepatocyte paraffin 1 antibody, a commonly used antibody in surgical pathology practice; and CPS1 expression appears to be down-regulated in liver cancer tissue and cell lines. The aim of this study is to understand how the CPS1 gene is regulated in liver carcinogenesis. In this report, we show that human hepatocellular carcinoma (HCC) cells do not express CPS1, whereas cultured human primary hepatocytes express abundant levels. In addition, CPS1 was silenced or down-regulated in liver tumor tissues compared with the matched noncancerous tissues. The expression of CPS1 in HCC cells was restored with a demethylation agent, 5-azacytidine. We show that two CpG dinucleotides, located near the transcription start site, and a CpG-rich region in the first intron were hypermethylated in HCC cells. The hypermethylation of the two CpG dinucleotides was also detected in HCC tumor tissues compared with noncancerous tissues. Further molecular analysis with mutagenesis indicated that the two CpG dinucleotides play a role in promoter activity of the CPS1 gene. In conclusion, our study demonstrates that DNA methylation is a key mechanism of silencing CPS1 expression in human HCC cells, and CPS1 gene hypermethylation of the two CpG dinucleotides is a potential biomarker for HCC.

摘要

氨甲酰磷酸合成酶 1(CPS1)是尿素循环中肝脏特异性的线粒体内部限速酶。先前的研究表明,CPS1 是肝石蜡 1 抗体的抗原,肝石蜡 1 抗体是外科病理学实践中常用的抗体;并且 CPS1 的表达似乎在肝癌组织和细胞系中下调。本研究旨在了解 CPS1 基因在肝癌发生中的调控机制。在本报告中,我们表明人肝癌(HCC)细胞不表达 CPS1,而培养的人原代肝细胞则表达丰富的 CPS1。此外,与匹配的非癌组织相比,CPS1 在肝肿瘤组织中被沉默或下调。用去甲基化剂 5-氮杂胞苷可恢复 HCC 细胞中的 CPS1 表达。我们表明,两个位于转录起始位点附近的 CpG 二核苷酸和第一个内含子中的 CpG 丰富区在 HCC 细胞中发生了甲基化。与非癌组织相比,HCC 肿瘤组织中也检测到两个 CpG 二核苷酸的高甲基化。进一步的突变分析表明,这两个 CpG 二核苷酸在 CPS1 基因启动子活性中起作用。总之,我们的研究表明,DNA 甲基化为人类 HCC 细胞中 CPS1 表达沉默的关键机制,并且 CPS1 基因的两个 CpG 二核苷酸的高甲基化是 HCC 的潜在生物标志物。

相似文献

1
DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma.DNA 甲基化抑制人肝癌细胞尿素循环酶氨甲酰磷酸合成酶 1(CPS1)的表达。
Am J Pathol. 2011 Feb;178(2):652-61. doi: 10.1016/j.ajpath.2010.10.023.
2
The activity of the carbamoyl phosphate synthase 1 promoter in human liver-derived cells is dependent on hepatocyte nuclear factor 3-beta.人肝源细胞中氨甲酰磷酸合成酶1启动子的活性依赖于肝细胞核因子3-β。
J Cell Mol Med. 2017 Sep;21(9):2036-2045. doi: 10.1111/jcmm.13123. Epub 2017 Mar 8.
3
Methylation of nucleolar and coiled-body phosphoprotein 1 is associated with the mechanism of tumorigenesis in hepatocellular carcinoma.核仁与卷曲体磷蛋白 1 的甲基化与肝癌的肿瘤发生机制有关。
Oncol Rep. 2013 Nov;30(5):2220-8. doi: 10.3892/or.2013.2676. Epub 2013 Aug 20.
4
Discovery of a Carbamoyl Phosphate Synthetase 1-Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis.通过综合基因组学和实验分析发现具有治疗潜力的氨甲酰磷酸合成酶 1 缺陷型 HCC 亚型。
Hepatology. 2021 Dec;74(6):3249-3268. doi: 10.1002/hep.32088. Epub 2021 Oct 11.
5
Y-box binding protein-1 down-regulates expression of carbamoyl phosphate synthetase-I by suppressing CCAAT enhancer-binding protein-alpha function in mice.Y盒结合蛋白1通过抑制小鼠CCAAT增强子结合蛋白α的功能下调氨甲酰磷酸合成酶I的表达。
Gastroenterology. 2009 Jul;137(1):330-40. doi: 10.1053/j.gastro.2009.02.064. Epub 2009 Mar 9.
6
Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc.氨甲酰磷酸合成酶 1 缺乏通过去泛素化 c-Myc 赋予肝癌放射抵抗性。
Int J Radiat Oncol Biol Phys. 2023 Apr 1;115(5):1244-1256. doi: 10.1016/j.ijrobp.2022.11.022. Epub 2022 Nov 22.
7
The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1.Hep Par 1抗体的抗原是尿素循环酶氨甲酰磷酸合成酶1。
Lab Invest. 2008 Jan;88(1):78-88. doi: 10.1038/labinvest.3700699. Epub 2007 Nov 19.
8
Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.人类肝细胞癌中异常的 CpG 岛甲基化和 Oct-6 mRNA 表达下调。
Dig Dis Sci. 2011 Oct;56(10):3072-7. doi: 10.1007/s10620-011-1686-y. Epub 2011 Mar 30.
9
Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.在乙型肝炎病毒相关肝细胞癌中,CpG岛DNA高甲基化导致GSTP1基因沉默。
Clin Cancer Res. 2002 Apr;8(4):1087-92.
10
Studies on the biological functions of CPS1 in AFB1 induced hepatocarcinogenesis.CPS1在黄曲霉毒素B1诱导的肝癌发生中的生物学功能研究。
Gene. 2016 Oct 10;591(1):255-261. doi: 10.1016/j.gene.2016.07.031. Epub 2016 Jul 15.

引用本文的文献

1
Investigating Liquid-Liquid Phase Separation in Lung Adenocarcinoma to Improve Prognostic Accuracy and Treatment Efficacy.研究肺腺癌中的液-液相分离以提高预后准确性和治疗效果。
J Cell Mol Med. 2025 Aug;29(16):e70807. doi: 10.1111/jcmm.70807.
2
Amino Acid Metabolism in Liver Mitochondria: From Homeostasis to Disease.肝脏线粒体中的氨基酸代谢:从稳态到疾病
Metabolites. 2025 Jul 2;15(7):446. doi: 10.3390/metabo15070446.
3
Urea cycle dysregulation: a new frontier in cancer metabolism and immune evasion.尿素循环失调:癌症代谢与免疫逃逸的新前沿。
Cell Commun Signal. 2025 Jul 1;23(1):307. doi: 10.1186/s12964-025-02328-3.
4
Enterocyte-like differentiation defines metabolic gene signatures of CMS3 colorectal cancers and provides therapeutic vulnerability.肠上皮细胞样分化定义了CMS3型结直肠癌的代谢基因特征并揭示了其治疗弱点。
Nat Commun. 2025 Jan 2;16(1):264. doi: 10.1038/s41467-024-55574-3.
5
Machine learning and multi-omics data reveal driver gene-based molecular subtypes in hepatocellular carcinoma for precision treatment.机器学习和多组学数据揭示了基于驱动基因的肝细胞癌分子亚型,以实现精准治疗。
PLoS Comput Biol. 2024 May 10;20(5):e1012113. doi: 10.1371/journal.pcbi.1012113. eCollection 2024 May.
6
A prognostic model based on DNA methylation-related gene expression for predicting overall survival in hepatocellular carcinoma.一种基于DNA甲基化相关基因表达的预测肝细胞癌总生存期的预后模型。
Front Oncol. 2024 Jan 18;13:1171932. doi: 10.3389/fonc.2023.1171932. eCollection 2023.
7
Genetics of enzymatic dysfunctions in metabolic disorders and cancer.代谢紊乱和癌症中酶功能障碍的遗传学
Front Oncol. 2023 Aug 2;13:1230934. doi: 10.3389/fonc.2023.1230934. eCollection 2023.
8
Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker.氨甲酰磷酸合成酶I表达不足作为肝内胆管癌独立的不良预后因素:一种潜在的治疗诊断生物标志物。
Diagnostics (Basel). 2023 Jul 6;13(13):2296. doi: 10.3390/diagnostics13132296.
9
Roles of NOLC1 in cancers and viral infection.NOLC1在癌症和病毒感染中的作用。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10593-10608. doi: 10.1007/s00432-023-04934-5. Epub 2023 Jun 9.
10
Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma.CRISPRa 技术介导的肿瘤抑制基因表观遗传激活作为肝细胞癌精准治疗的策略。
Clin Epigenetics. 2023 Apr 29;15(1):73. doi: 10.1186/s13148-023-01482-0.

本文引用的文献

1
Epigenetics in cancer: targeting chromatin modifications.癌症中的表观遗传学:靶向染色质修饰
Mol Cancer Ther. 2009 Jun;8(6):1409-20. doi: 10.1158/1535-7163.MCT-08-0860. Epub 2009 Jun 9.
2
SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle.SIRT5使氨甲酰磷酸合成酶1去乙酰化并调节尿素循环。
Cell. 2009 May 1;137(3):560-70. doi: 10.1016/j.cell.2009.02.026.
3
Y-box binding protein-1 down-regulates expression of carbamoyl phosphate synthetase-I by suppressing CCAAT enhancer-binding protein-alpha function in mice.Y盒结合蛋白1通过抑制小鼠CCAAT增强子结合蛋白α的功能下调氨甲酰磷酸合成酶I的表达。
Gastroenterology. 2009 Jul;137(1):330-40. doi: 10.1053/j.gastro.2009.02.064. Epub 2009 Mar 9.
4
Arginine deprivation as a targeted therapy for cancer.精氨酸剥夺作为一种癌症靶向治疗方法。
Curr Pharm Des. 2008;14(11):1049-57. doi: 10.2174/138161208784246199.
5
DNA methylation in hepatocellular carcinoma.肝细胞癌中的DNA甲基化
World J Gastroenterol. 2008 Mar 21;14(11):1741-8. doi: 10.3748/wjg.14.1741.
6
The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1.Hep Par 1抗体的抗原是尿素循环酶氨甲酰磷酸合成酶1。
Lab Invest. 2008 Jan;88(1):78-88. doi: 10.1038/labinvest.3700699. Epub 2007 Nov 19.
7
Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.丙型肝炎病毒通过抗病毒防御系统触发新建立的肝癌细胞系的凋亡。
Gastroenterology. 2007 Nov;133(5):1649-59. doi: 10.1053/j.gastro.2007.09.017. Epub 2007 Sep 16.
8
Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension.先天性心脏病手术患儿静脉注射瓜氨酸的药代动力学和安全性:对术后肺动脉高压的潜在治疗作用
J Thorac Cardiovasc Surg. 2007 Aug;134(2):319-26. doi: 10.1016/j.jtcvs.2007.02.043.
9
Genetic variation in the mitochondrial enzyme carbamyl-phosphate synthetase I predisposes children to increased pulmonary artery pressure following surgical repair of congenital heart defects: a validated genetic association study.线粒体酶氨基甲酰磷酸合成酶I的基因变异使儿童在先天性心脏缺陷手术修复后肺动脉压力升高:一项经过验证的基因关联研究。
Mitochondrion. 2007 May;7(3):204-10. doi: 10.1016/j.mito.2006.11.001. Epub 2006 Nov 29.
10
Hepatocyte-specific interplay of transcription factors at the far-upstream enhancer of the carbamoylphosphate synthetase gene upon glucocorticoid induction.糖皮质激素诱导后,转录因子在氨甲酰磷酸合成酶基因远上游增强子处的肝细胞特异性相互作用。
FEBS J. 2007 Jan;274(1):37-45. doi: 10.1111/j.1742-4658.2006.05561.x. Epub 2006 Nov 28.